CRSP logo

CRISPR Therapeutics AG (CRSP) Price To Sales Ratio

PS Ratio

107.44
+3.29+3.16%

5 min ago


Summary


Performance

CRSP PS Ratio Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherCRSPvaluationmetrics:

PS Ratio Formula

P/S =  
Market capitalization
TTM Revenue

CRSP PS Ratio Trends

PeriodPeriodPS ratioPS ratioPricePriceMarket capMarket capTTM revenueTTM revenue
todaytoday+3.2%+3.1%+3.1%-
1 m1 month+1.0%+1.0%+1.0%-
3 m3 months--4.1%-3.6%-
6 m6 months--3.6%-3.0%-
ytdytd+11.5%+11.4%+11.5%-
1 y1 year+526.1%-41.9%-40.8%-
5 y5 years+1241.3%+15.0%+62.1%-

CRSP PS Ratio Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-17.3%98.04+9.6%
3 m3-month129.94-17.3%94.12+14.2%
6 m6-month129.94-17.3%94.12+14.2%
1 y1-year129.94-17.3%15.66+586.1%
3 y3-year10.08 K-98.9%3.67+2827.5%
5 y5-year28.59 K-99.6%3.67+2827.5%
alltimeall time28.59 K-99.6%3.67+2827.5%

CRISPR Therapeutics AG PS Ratio History

DateValue
2025
107.44(+11.5%)
2024
96.37(+609.6%)
2023
13.58(-99.8%)
2022
7523.51(>+9900.0%)
2021
6.39(-100.0%)
DateValue
2020
20.84 K(>+9900.0%)
2019
12.78(-97.3%)
2018
474.21(+1939.6%)
2017
23.25(-85.1%)
2016
155.83

FAQ

  • What is CRISPR Therapeutics AG price to sales ratio?
  • What is the all time high PS ratio for CRISPR Therapeutics AG?
  • What is CRSP price to sales ratio year-to-date change?
  • What is CRISPR Therapeutics AG PS ratio year-on-year change?

What is CRISPR Therapeutics AG price to sales ratio?

The current PS ratio of CRSP is 107.44

What is the all time high PS ratio for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high price to sales ratio is 28.59 K

What is CRSP price to sales ratio year-to-date change?

CRISPR Therapeutics AG price to sales ratio has changed by +11.07 (+11.49%) since the beginning of the year

What is CRISPR Therapeutics AG PS ratio year-on-year change?

Over the past year, CRSP price to sales ratio has changed by +90.28 (+526.11%)